Literature DB >> 6352519

Double minutes in acute myeloid leukemia.

Y S Li.   

Abstract

Five out of 110 patients with acute myeloid leukemia (AML) showed double minutes (DM) in cytogenetic preparations. DM were found to occur predominantly in elderly patients, and in erythroleukemia or acute myelomonocytic leukemia. The five patients were apparently divided into two groups according to the number of DM per cell. Patients with few sets of DM had exclusively complex karyotypes and a poor prognosis while patients with numerous DM had otherwise normal or nearly normal karyotypes and a good prognosis. Data on 11 previously reported cases of AML with DM were collected from the literature and consistent results were revealed except that several of the 11 patients were diagnosed as having acute myeloblastic leukemia (M1 and M2 in the FAB classification), which is apparently due to differences in diagnostic criteria. Therefore, numerous or few DM in a cell might relate to different entities. When the number of DM was small they might have resulted from breakdown of existing chromosomes.

Entities:  

Mesh:

Year:  1983        PMID: 6352519     DOI: 10.1002/ijc.2910320411

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  2 in total

1.  Genomic amplification of MYC as double minutes in a patient with APL-like leukemia.

Authors:  Pino J Poddighe; Hans Wessels; Pauline Merle; Marisa Westers; Shama Bhola; Anne Loonen; Sonja Zweegman; Gert J Ossenkoppele; Marielle J Wondergem
Journal:  Mol Cytogenet       Date:  2014-10-22       Impact factor: 2.009

2.  Met promotes the formation of double minute chromosomes induced by Sei-1 in NIH-3T3 murine fibroblasts.

Authors:  Yantao Bao; Jia Liu; Jia You; Di Wu; Yang Yu; Chang Liu; Lei Wang; Fei Wang; Lu Xu; Liqun Wang; Nan Wang; Xing Tian; Falin Wang; Hongbin Liang; Yating Gao; Xiaobo Cui; Guohua Ji; Jing Bai; Jingcui Yu; Xiangning Meng; Yan Jin; Wenjing Sun; Xin-Yuan Guan; Chunyu Zhang; Songbin Fu
Journal:  Oncotarget       Date:  2016-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.